Search

News

Search in All Title Contents

 Almost six hundred acute leukemia specialists from 12 different countries have joined the annual meeting, in a virtual format this year

  The arrival of immunotherapy, novelties in FLT3 inhibitors in acute myeloid leukemia and management of the disease alongside COVID-19 were some of the most outstanding topics at the meeting

MD Anderson Cancer Center Madrid opens its 9th Annual Meeting on Acute Leukemia next Thursday, September 24, co-organized, as on previous occasions by Dr. Adolfo de la Fuente, head of the Hematology Service at the center and Dr. Miguel Angel Sanz, of La Fe University and Polytechnic Hospital in Valencia. The conference, with more than three hundred expert participants in the pathology, will have a new, 100% virtual format this year.

In more than 95% of the health centers in our country, molecular diagnosis is not performed in patients with thyroid cancer

One in five patients could benefit from the incorporation of RET inhibitors, targeted drugs that have given response rates of 70% in patients with metastatic thyroid cancer

In addition to RET alterations, there are others like those that affect the BRAF, NTRK or mTOR genes, which in total may affect 80% of patients with differentiated thyroid cancer, the most common subtype

It is essential that all cancer patients undergo an oral examination to ensure there is no active infection before starting cancer treatment. Chemotherapy can cause gum disease, while radiation therapy to the head and neck often causes tooth decay and dry mouth

Tags
mri
VPH